Inhibrx Biosciences Inc's total assets for Q1 2025 were $242.64M, an increase of 34.23% from the previous quarter. INBX total liabilities were $148.20M for the fiscal quarter, a 214.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.